 |
|||
 |
 |
 |
|
Hepatitis C
HCV Pre-clinical Program
Our research on the treatment of hepatitis C virus (HCV) infection is based on HCV-entry inhibition, i.e. preventing HCV from entering healthy liver cells.
Our research and development team has built a robust platform for HCV drug discovery. We anticipate selecting a development candidate for the treatment of HCV from a pre-clinical portfolio of candidates.